Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Complement Activation Fragments Are Increased in Critically Ill Pediatric Patients with Severe AKI.
Stenson EK, You Z, Reeder R, Norris J, Scott HF, Dixon BP, Thurman JM, Frazer-Abel A, Mourani P, Kendrick J; Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network. Stenson EK, et al. Among authors: dixon bp. Kidney360. 2021 Oct 7;2(12):1884-1891. doi: 10.34067/KID.0004542021. eCollection 2021 Dec 30. Kidney360. 2021. PMID: 35419539 Free PMC article.
Editorial: Autoantibodies in Kidney Diseases.
Marchbank KJ, Frazer-Abel A, Dragon-Durey MA, Dixon BP. Marchbank KJ, et al. Among authors: dixon bp. Front Immunol. 2020 Sep 16;11:591338. doi: 10.3389/fimmu.2020.591338. eCollection 2020. Front Immunol. 2020. PMID: 33042166 Free PMC article. No abstract available.
The complement system in pediatric acute kidney injury.
Stenson EK, Kendrick J, Dixon B, Thurman JM. Stenson EK, et al. Pediatr Nephrol. 2023 May;38(5):1411-1425. doi: 10.1007/s00467-022-05755-3. Epub 2022 Oct 6. Pediatr Nephrol. 2023. PMID: 36203104 Free PMC article. Review.
Urine Complement Factor Ba Is Associated with AKI in Critically Ill Children.
Stenson EK, Edelstein CL, You Z, Miyazaki-Anzai S, Thurman JM, Dixon BP, Zappitelli M, Goldstein SL, Akcan Arikan A, Kendrick J. Stenson EK, et al. Among authors: dixon bp. Kidney360. 2023 Mar 1;4(3):326-332. doi: 10.34067/KID.0000000000000077. Kidney360. 2023. PMID: 36758197 Free PMC article.
The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.
Ariceta G, Dixon BP, Kim SH, Kapur G, Mauch T, Ortiz S, Vallee M, Denker AE, Kang HG, Greenbaum LA; 312 Study Group. Ariceta G, et al. Among authors: dixon bp. Kidney Int. 2021 Jul;100(1):225-237. doi: 10.1016/j.kint.2020.10.046. Epub 2020 Dec 8. Kidney Int. 2021. PMID: 33307104 Free article. Clinical Trial.
Acute kidney injury requiring kidney replacement therapy in childhood lupus nephritis: a cohort study of the Pediatric Nephrology Research Consortium and Childhood Arthritis and Rheumatology Research Alliance.
Stotter BR, Cody E, Gu H, Daga A, Greenbaum LA, Duong MD, Mazo A, Goilav B, Boneparth A, Kallash M, Zeid A, Seeherunvong W, Scobell RR, Alhamoud I, Carter CE, Shah S, Straatmann CE, Dixon BP, Cooper JC, Nelson RD, Levy DM, Brunner HI, Verghese PS, Wenderfer SE. Stotter BR, et al. Among authors: dixon bp. Pediatr Nephrol. 2023 May;38(5):1653-1665. doi: 10.1007/s00467-022-05775-z. Epub 2022 Oct 17. Pediatr Nephrol. 2023. PMID: 36251074
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan.
Podos SD, Trachtman H, Appel GB, Bomback AS, Dixon BP, Wetzels JFM, Cook HT, Parikh SV, Pickering MC, Tumlin J, Langman CB, Lightstone L, Sperati CJ, Daina E, Bouman KP, Rice K, Thanassi JA, Huang M, Nester C, Remuzzi G. Podos SD, et al. Among authors: dixon bp. Am J Nephrol. 2022;53(10):675-686. doi: 10.1159/000527166. Epub 2022 Nov 18. Am J Nephrol. 2022. PMID: 36404708 Free article. Clinical Trial.
48 results